Financial Summary (All financials)
In millions, except per share items | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 |
Revenues | 23.9 | 75.6 | 138.9 | 109.6 | 89.7 | 52.3 | 35.5 | 63.9 |
Revenue growth | -68.4% | -45.6% | 26.7% | 22.3% | 71.6% | 47.3% | -44.5% | -77.4% |
Cost of goods sold | -335.8 | -274.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross profit | 359.7 | 350.3 | 138.9 | 109.6 | 89.7 | 52.3 | 35.5 | 63.9 |
Gross margin | 1507.0% | 463.4% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
Selling, general and administrative | | | | 184.3 | | | | |
Research and development | 144.5 | 124.0 | 149.2 | 119.9 | 126.0 | 106.5 | 104.0 | 80.3 |
General and administrative | 149.8 | 85.1 | 82.2 | | 48.1 | 45.2 | 41.1 | 43.7 |
EBITA | -296.7 | -144.6 | -91.4 | -73.2 | -83.4 | -98.3 | -108.5 | -59.0 |
EBITA margin | -1243.0% | -191.2% | -65.8% | -66.8% | -93.0% | -188.2% | -306.0% | -92.4% |
Amortization of intangibles | 1.2 | 1.2 | 1.2 | 1.5 | 1.1 | 1.1 | 1.1 | 1.1 |
EBIT | -297.8 | -145.7 | -92.6 | -74.7 | -84.4 | -99.4 | -109.6 | -60.1 |
EBIT margin | -1247.8% | -192.8% | -66.6% | -68.2% | -94.2% | -190.2% | -309.0% | -94.0% |
Pre-tax income | -290.1 | -176.1 | -88.1 | -21.0 | -83.3 | -98.6 | -108.4 | -58.6 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -290.1 | -176.1 | -88.1 | -21.0 | -83.3 | -98.6 | -108.4 | -58.6 |
Net margin | -1215.2% | -232.9% | -63.4% | -19.2% | -92.9% | -188.7% | -305.7% | -91.8% |
|
Diluted EPS | ($2.92) | ($2.26) | ($1.20) | ($0.31) | ($1.32) | ($1.91) | ($2.13) | ($1.16) |
Shares outstanding (diluted) | 99.3 | 77.8 | 73.1 | 68.7 | 63.1 | 51.7 | 50.9 | 50.4 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|